Sign In
Last checked at 
20 Dec 2021 13:08
PDMR Dealing
genedrive plc (LSE: GDR) ("genedrive" or the "Company"), the near patient molecular diagnostics company, announces that it has been notified of the following transaction by Matthew Fowler, a person discharging managerial responsibilities, and his wife who is a person closely associated with him.
Following the transfer outlined below, Matthew Fowler's total beneficial interest remains unchanged at 139,457 Ordinary Shares.
This notification is made in accordance with the Market Abuse Regulation.
The information set out below is provided in accordance with the requirements of Article 19(3) of the EU Market Abuse Regulation No 596/2014.
1. | Details of the person discharging managerial responsibilities / person closely associated | |
a. | Name | Matthew Fowler
|
2. | Reason for the notification | |
a. | Position/status | PDMR, CFO |
a. | Initial notification /Amendment | Initial notification |
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
a. | Name | genedrive plc |
b. | LEI | 213800ZYODIRZ87Y4K14 |
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
a. | Description of the Financial instrument, type of instrument Identification code | Ordinary shares of 1.5 pence each
GB00B1VKB244 |
b. | Nature of the transaction | Transfer of shares to Alison Fowler (spouse) for nil consideration. |
c. | Price(s) and volume(s) |
Price £nil
Volume(s) 50,000
|
d. | Aggregated information ·Aggregated volume ·Price
|
50,000
Nil
|
e. | Date of the transaction | 2021-12-20 |
f. | Place of the transaction | Outside a trading venue |
For further details please contact:
genedrive plc | +44 (0)161 989 0245 |
David Budd: CEO / Matthew Fowler: CFO | |
Peel Hunt LLP (Nominated Adviser and Joint Broker) | +44 (0)20 7418 8900 |
James Steel | |
finnCap (Joint Broker) | +44 (0)20 7220 500 |
Geoff Nash / Kate Bannatyne / Alice Lane | |
Walbrook PR Ltd (Media Relations & Investor Relations) | +44 (0)20 7933 8780 or genedrive@walbrookpr.com |
Paul McManus / Anna Dunphy | +44 (0)7980 541 893 / +44 (0)7876 741 001 |
Follow the stocks
